Biochemical Modulation: Its Pharmacological Basis and Clinical ApplicationsLOW CHENG HOCK.Oncology. 1997, Vol 54, issn 0030-2414, 42 p., SUP1Conference Proceedings

GENERAL PHARMACOLOGICAL PROPERTIES OF UFT A NEW TYPE OF ANTI-CANCER AGENT CONSISTING OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL (FT) AND URACIL. I: PHARMACOLOGICAL ANALYSIS OF THE COMBINED EFFECT OF FT AND URACILYAMAMOTO J; TOIDE K; HARUNO A et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 8; PP. 1268-1278; ABS. GER; BIBL. 25 REF.Article

Oral Tegafur/folinic acid chemotherapy decreases phenytoin efficacyVELDHORST-JANSSEN, N. M. L; BOERSMA, H. H; DE KROM, Mctfm et al.British journal of cancer. 2004, Vol 90, Num 3, issn 0007-0920, p. 745Article

Tegafur-induced photosensitivity : evaluation of provocation by UVB irradiationUSUKI, A; FUNASAKA, Y; OKA, M et al.International journal of dermatology. 1997, Vol 36, Num 8, pp 604-606, issn 0011-9059Article

Contrasting effects of extended low dose versus standard dose shorter course UFT chemotherapy on microscopic versus macroscopic established tumors : Implications for optimal postoperative adjuvant chemotherapyUCHIDA, Junji; OKABE, Hiroyuki; NAKANO, Koushi et al.Oncology reports. 2007, Vol 18, Num 2, pp 313-319, issn 1021-335X, 7 p.Article

Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer a randomised controlled studyOHWADA, S; LKEYA, T; KAWATE, S et al.British journal of cancer. 2004, Vol 90, Num 5, pp 1003-1010, issn 0007-0920, 8 p.Article

Cytosolic and microsomal activation of doxifluridine and tegafur to produce 5-fluorouracil in human liverOZAWA, Shogo; HAMADA, Masashi; MURAYAMA, Norie et al.Cancer chemotherapy and pharmacology. 2002, Vol 50, Num 6, pp 454-458, issn 0344-5704, 5 p.Article

ANN-QSAR model for selection of anticancer leads from structurally heterogeneous series of compoundsGONZALEZ-DIAZ, Humberto; BONET, Isis; TERAN, Carmen et al.European journal of medicinal chemistry. 2007, Vol 42, Num 5, pp 580-585, issn 0223-5234, 6 p.Article

A novel mutant allele of the CYP2A6 gene (CYP2A6*11) found in a cancer patient who showed poor metabolic phenotype towards tegafurDAIGO, Satoshi; TAKAHASHI, Yoshiki; NISHIOKA, Yasuhiko et al.Pharmacogenetics (London). 2002, Vol 12, Num 4, pp 299-306, issn 0960-314XArticle

An oral repeated dose toxicity study of a new antineoplastic agent S-1 in dogs. I. A 13-week repeated dose toxicity study. II. An ophthalmologic toxicity recovery studyHAYASHI, T; YAMAGUCHI, S; KITO, S et al.Journal of toxicological sciences. 1996, Vol 21, pp 527-544, issn 0388-1350, SUP3Article

Antigenicity tests of a new antineoplastic agent S-1MAEDA, Y; MORINAGA, H; IZUMI, K et al.Journal of toxicological sciences. 1996, Vol 21, pp 661-673, issn 0388-1350, SUP3Article

Formation Pathways of γ-Butyrolactone from the Furan Ring of Tegafur during Its Conversion to 5-FluorouracilYAMAMIYA, Ikuo; YOSHISUE, Kunihiro; MATSUSHIMA, Eiji et al.Drug metabolism and disposition. 2010, Vol 38, Num 8, pp 1267-1276, issn 0090-9556, 10 p.Article

The effect of tegafur and Uracil combination on colonic anastomotic strength: An experimental study on ratsKURT, Necmi; TARCAN, Ercument; CÖKMEZ, Atilla et al.Hepato-gastroenterology. 2004, Vol 51, Num 55, pp 128-130, issn 0172-6390, 3 p.Article

UFT® plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy : A comprehensive reviewMINSKY, Bruce D.International journal of cancer. 2001, Vol 96, Num 1, pp 1-10, issn 0020-7136Article

Improving fluorouracil chemotherapy with novel orally administered fluoropyrimidinesDIASIO, R. B.Drugs (Basel). 1999, Vol 58, pp 119-126, issn 0012-6667, SUP3Conference Paper

Induction of apoptosis in human tumour xenografts after oral administration of uracil and tegafur to nude mice bearing tumoursOKI, E; SAKAGUCHI, Y; TOH, Y et al.British journal of cancer. 1998, Vol 78, Num 5, pp 625-630, issn 0007-0920Article

A 26-week oral repeated dose toxicity study of a new antineoplastic agent S-1 in ratsHAKOI, K; HAYASHI, T; OHMAE, S et al.Journal of toxicological sciences. 1996, Vol 21, pp 545-560, issn 0388-1350, SUP3Article

Reproductive and developmental toxicity study of a new antineoplastic agent, S-1. III : Teratological study in rabbits by oral administrationSHINOMIYA, M; YUKIYAMA, S; IKEBUCHI, K et al.Journal of toxicological sciences. 1996, Vol 21, pp 619-641, issn 0388-1350, SUP3Article

IMPROVED LIQUID CHROMATOGRAPHIC ASSAY FOR SERUM FLUOROURACIL CONCENTRATIONS IN THE PRESENCE OF FTORAFURHORNBECK CL; FLOYD RA; GRIFFITHS JC et al.1981; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1981; VOL. 70; NO 10; PP. 1163-1166; BIBL. 10 REF.Article

Optimization of Sample Preparation Conditions for Detecting Trace Amounts of β-Tegafur in α- and β-Tegafur MixtureBOBROVS, Raitis; ACTINS, Andris.Journal of pharmaceutical sciences. 2012, Vol 101, Num 12, pp 4608-4614, issn 0022-3549, 7 p.Article

Determination of tegafur, 5-fluorouracil, gimeracil and oxonic acid in human plasma using liquid chromatography―tandem mass spectrometryKE LIU; DAFANG ZHONG; HUIYU ZOU et al.Journal of pharmaceutical and biomedical analysis. 2010, Vol 52, Num 4, pp 550-556, issn 0731-7085, 7 p.Article

Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN)KATORI, Hideaki; TSUKUDA, Mamoru; TAGUCHI, Takahide et al.Acta oto-laryngologica. 2007, Vol 127, Num 10, pp 1099-1104, issn 0001-6489, 6 p.Article

Low thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafurGRAU, Juan J; DOMINGO-DOMENECH, Josep; MORENTE, Vanesa et al.Oncology. 2004, Vol 66, Num 3, pp 226-233, issn 0030-2414, 8 p.Article

Determination of 5-fluorouracil and its prodrug tegafur in plasma and tissue by high-performance liquid chromatography in a single injection: Validation for application in clinical pharmacokinetic studiesZUFIA, Laura; ALDAZ, Azucena; CASTELLANOS, Carmen et al.Therapeutic drug monitoring. 2003, Vol 25, Num 2, pp 221-228, issn 0163-4356, 8 p.Article

Kinetics and mechanism of Ftorafur ^® solvolysis. III: Log k-pH profile for Ftorafur solvolysisHERMANN, T; GRZESKOWIAK, E.Pharmazie. 1983, Vol 38, Num 9, pp 633-634, issn 0031-7144Article